Business

Innate Pharma announces conference call and webcast for Q1 2025 business update

MARSEILLE, France, May 06, 2025--Innate Pharma announces conference call and webcast for Q1 2025 business update

articleInnate Pharma Sa Class AMay 6, 20254/company/innate-pharma-sa-class-a/news/innate-pharma-announces-conference-call-and-webcast-for-q1-2025-business-update
Innate Pharma announces conference call and webcast for Q1 2025 business update

About this update from Innate Pharma Sa Class A

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/9b5292e420f5132c4ccf458d3fa01171"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/KcsmKvQ_7_rP0zOO.XpI6g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/9b5292e420f5132c4ccf458d3fa01171","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/itkTzqJNsBV5iEDKad8GFw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0O2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/9b5292e420f5132c4ccf458d3fa01171","width":1024,"height":512}},"lazy":false},{"type":"text","content":"MARSEILLE, France, May 06, 2025--(BUSINESS WIRE)--Regulatory News:","length":66,"tagName":"p"},{"type":"text","content":"Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company"), today announced that the Company will hold a conference call on Tuesday, May 13, 2025, at 2 p.m. CEST / 8 a.m. EDT, to give an update on business progress during the first quarter of 2025.","length":290,"tagName":"p"},{"type":"text","content":"In addition, members of the executive management team will be meeting with investors in New York and Boston from May 13 to May 14, 2025.","length":136,"tagName":"p"},{"type":"text","content":"Participants during the call will be:","length":37,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Jonathan Dickinson, Chief Executive Officer","length":43,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Sonia Quaratino, Executive Vice President, Chief Medical Officer","length":64,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Yannis Morel, Executive Vice President, Chief Operating Officer","length":63,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Frédéric Lombard, Senior Vice President, Chief Financial Officer","length":64,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":234,"olType":false},{"type":"text","content":"Details for the Virtual Event","length":29,"tagName":"p"},{"type":"text","content":"The live webcast will be available at the following link:","length":57,"tagName":"p","attribs":{}},{"type":"text","content":"https://events.q4inc.com/attend...

More updates from Innate Pharma Sa Class A

Euronext ParisInnate PharmaExecutive Vice Presidentthe CompanyCompanyChief Medical OfficerJonathan Dickinson